Evotec SE (Evotec SE) Days Payable

: 58.86 (As of Sep. 2023)

View and export this data going back to . Start your Free Trial

Evotec SE's average Accounts Payable for the three months ended in Sep. 2023 was $109.1 Mil. Evotec SE's Cost of Goods Sold for the three months ended in Sep. 2023 was $169.1 Mil. Hence, Evotec SE's Days Payable for the three months ended in Sep. 2023 was 58.86.

The historical rank and industry rank for Evotec SE's Days Payable or its related term are showing as below:

EVOTF' s Days Payable Range Over the Past 10 Years
Min: 35.93 Med: 42.13 Max: 79.53
Current: 79.53

During the past 13 years, Evotec SE's highest Days Payable was 79.53. The lowest was 35.93. And the median was 42.13.

EVOTF's Days Payable is ranked worse than
54.85% of 979 companies
in the Drug Manufacturers industry
Industry Median: 86.3 vs EVOTF: 79.53

Evotec SE's Days Payable increased from Jun. 2022 (51.26) to Sep. 2023 (58.86). It may suggest that Evotec SE delayed paying its suppliers.

Evotec SE Days Payable Historical Data

The historical data trend for Evotec SE's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

40.37

36.79

34.61

46.32

55.22

Evotec SE Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial															51.26	53.42	50.68	74.04	58.86

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evotec SE Days Payable Distribution

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Days Payable distribution charts can be found below:

* The bar in red indicates where Evotec SE's Days Payable falls into.

Evotec SE Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Evotec SE's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (82.032	+	103.048)	/	2 )	/	611.634	*	365
=	92.54					/	611.634	*	365
=	55.22

Evotec SE's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (114.884	+	103.281)	/	2 )	/	169.109	*	365 / 4
=	109.0825					/	169.109	*	365 / 4
=	58.86

Evotec SE Days Payable Related Terms

Thank you for viewing the detailed overview of Evotec SE's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Evotec SE (Evotec SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (OTCPK:EVOTF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

EVO:USA 1EVT:Italy EVTd:UK 0IRF:UK EVT:Germany EVT:Austria

Address

Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419

Website

https://www.evotec.com

Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.